Follow
IRLAB Therapeutics AB
IRLAB Therapeutics AB is a Swedish based drug discovery and development company providing novel treatments for disorders of the brain. The company focusses on the innovative treatments and quality of life for patients with neurological and psychiatric illnesses. It is engaged in programs targeting core dysfunctions in Parkinson's disease and dementias. In addition, it is also involved in clinical development of novel compounds which aims at offering improved clinical benefit for patients with Parkinson's di IRLAB Therapeutics AB is a Swedish based drug discovery and development company providing novel treatments for disorders of the brain. The company focusses on the innovative treatments and quality of life for patients with neurological and psychiatric illnesses. It is engaged in programs targeting core dysfunctions in Parkinson's disease and dementias. In addition, it is also involved in clinical development of novel compounds which aims at offering improved clinical benefit for patients with Parkinson's disease.

Read more

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
Status
This company has moved to a main market, therfore we do not show updates relating to this company.
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
IRLAB A
SE0012675361
Details of share in IRLAB Therapeutics AB with ticker IRLAB A
Status
Active
Order book id
Amount of instruments
48 418 630
Par value
0.1000
Market cap
Currency
SEK
Segment
First North Premier
First trading date
28 Feb 2017
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
60.00 SEK
304.2M SEK
30 Jan - 10 Feb 2017
IPO in IRLAB Therapeutics AB
Type
Price
Pre-money valuation
Time
Files
Directed issue
126.00 SEK
23 May 2018
Share issue in IRLAB Therapeutics AB
Type
Price
Pre-money valuation
Time
Files
Directed issue
27.00 SEK
12 Dec 2019
Share issue in IRLAB Therapeutics AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
27.00 SEK
11 Feb - 25 Feb 2020
Share issue in IRLAB Therapeutics AB
Type
Price
Pre-money valuation
Time
Files
Market move
48.50 SEK
2.35B SEK
30 Sep 2020
Listing of IRLAB Therapeutics AB on NASDAQ STOCKHOLM
People
Number of Employees
19 people
Nicholas Waters
CEO
Anders Vedin
Chairman of the board
Anders Vedin
Board member
Eva Lindgren
Board member
Hans-Peter Ostler
Board member
Rein Piir
Board member
Jacob Testor
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Arvid Wallgrens Backe 20
Zip code
413 46
City/district
Göteborg
Country
Sweden (SE)
Registration number
556931-4692
LEI code
549300JAT34LHEI0DH60
First trade date
28 Feb 2017
Registration date
16 May 2013
Short name
IRLAB Therapeutics

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date